2005
DOI: 10.1016/j.ccr.2004.11.022
|View full text |Cite
|
Sign up to set email alerts
|

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase

Abstract: Several mitochondrial proteins are tumor suppressors. These include succinate dehydrogenase (SDH) and fumarate hydratase, both enzymes of the tricarboxylic acid (TCA) cycle. However, to date, the mechanisms by which defects in the TCA cycle contribute to tumor formation have not been elucidated. Here we describe a mitochondrion-to-cytosol signaling pathway that links mitochondrial dysfunction to oncogenic events: succinate, which accumulates as a result of SDH inhibition, inhibits HIF-alpha prolyl hydroxylases… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

47
1,423
1
18

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,759 publications
(1,489 citation statements)
references
References 40 publications
(13 reference statements)
47
1,423
1
18
Order By: Relevance
“…Importantly, mutations in the gene encoding succinate dehydrogenase (SDH), the enzyme responsible for the conversion of succinate to fumarate, were implicated in several cancers, and SDH is now regarded as a tumor suppressor [42]. SDH mutations result in the accumulation of succinate and subsequent HIF-1a stabilization [43], thereby providing a growth advantage for tumors. HIF-1 is a transcriptional regulator in the switch to glycolysis [22] and has been shown to be an important target for succinate.…”
Section: Box 1 the Relationship Between Succinate And Hif-1a In Cancermentioning
confidence: 99%
“…Importantly, mutations in the gene encoding succinate dehydrogenase (SDH), the enzyme responsible for the conversion of succinate to fumarate, were implicated in several cancers, and SDH is now regarded as a tumor suppressor [42]. SDH mutations result in the accumulation of succinate and subsequent HIF-1a stabilization [43], thereby providing a growth advantage for tumors. HIF-1 is a transcriptional regulator in the switch to glycolysis [22] and has been shown to be an important target for succinate.…”
Section: Box 1 the Relationship Between Succinate And Hif-1a In Cancermentioning
confidence: 99%
“…Since HIF-regulating prolyl-4-hydroxylases utilise -ketoglutarate as a co-substrate and produce succinate during their catalytic activity, it is not surprising that the accumulation of succinate blocks these hydroxylases [27]. Indeed, loss-of-function mutations in succinate dehydrogenase were found to be inhibitory towards PHDs leading to the stabilisation of HIF- subunits and succinate was identified as the mediator of this effect [28,29]. Thus, PHDs can also integrate metabolism-dependent stimuli in the regulation of HIF- which, in return, induces a panel of adaptive genes forming a classical feedforward loop.…”
Section: Metabolic Feedbackmentioning
confidence: 99%
“…The first hypothesis postulates that SDH and FH deficiencies increase the production of ROS (Messner and Imlay, 2002;Yankovskaya et al, 2003). An alternative model proposes that succinate, which accumulates due to TCA cycle impairment, acts as a signalling molecule and triggers the activation of hypoxia inducible factor 1a (HIF1a) (Selak et al, 2005). Hypoxia inducible factor 1a promotes adaptation of cells to low-oxygen consumption and activates the transcription of glycolytic genes (Firth et al, 1995;Semenza et al, 1996), stimulating aerobic glycolysis.…”
Section: Mitochondrial Physiology In Cell Proliferation and Tumour Prmentioning
confidence: 99%